{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:25:51Z","timestamp":1791951951747,"version":"4.3.4"},"reference-count":358,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.040","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T05:51:02Z","timestamp":1662097862000},"page":"538-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Long-acting formulation strategies for protein and peptide delivery in the treatment of PSED"],"prefix":"10.1016","volume":"350","author":[{"given":"Atul","family":"Garkal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Bangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjitsing","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Pingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namdev","family":"Dhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Sami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushboo","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika","family":"Dhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaivat","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Mutalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.08.040_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijbiomac.2018.01.120","article-title":"Biological macromolecules for ophthalmic drug delivery to treat ocular diseases","volume":"110","author":"Krishnaswami","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","article-title":"Ocular delivery of proteins and peptides: challenges and novel formulation approaches","volume":"126","author":"Mandal","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0025","first-page":"1","article-title":"Drug delivery for the retina and posterior segment disease","author":"Patel","year":"2018","journal-title":"Springer Int. Publ."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-813667-6.00004-8","article-title":"Nanotechnology for ocular drug delivery","author":"Agarwal","year":"2018","journal-title":"Des. Nanostruct. Versatile Ther. Appl."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0035","first-page":"90","article-title":"Lipid nanoparticles for the posterior eye segment","volume":"14","author":"Jablonski","year":"2022","journal-title":"Pharm"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.colcom.2018.03.008","article-title":"Recent developments in ophthalmic drug delivery systems for therapy of both anterior and posterior segment diseases","volume":"24","author":"Chen","year":"2018","journal-title":"Colloids Interface Sci. Commun."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109518","article-title":"Sirolimus loaded polyol modified liposomes for the treatment of posterior segment eye diseases","volume":"136","author":"Suri","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0050","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0055","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.drudis.2019.05.035","article-title":"Challenges and opportunities for drug delivery to the posterior of the eye","volume":"24","author":"Cabrera","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0060","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.biopha.2018.08.138","article-title":"A review on recent drug delivery systems for posterior segment of eye","volume":"107","author":"Nayak","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0065","first-page":"1","article-title":"Development of 3D printed bruch\u2019s membrane-mimetic substance for the maturation of retinal pigment epithelial cells","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109964","article-title":"Development of an in vitro 3D choroidal neovascularization model using chemically induced hypoxia through an ultra-thin, free-standing nanofiber membrane","volume":"104","author":"Park","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0075","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.oret.2020.01.012","article-title":"Progression from early\/intermediate to advanced forms of age-related macular degeneration in a large UK cohort: rates and risk factors","volume":"4","author":"Chakravarthy","year":"2020","journal-title":"Ophthalmol. Retin."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0080","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0085","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00018-019-03420-x","article-title":"Senescence in the pathogenesis of age-related macular degeneration","volume":"77","author":"Blasiak","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","article-title":"Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex","volume":"33","author":"Bhutto","year":"2012","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0095","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/cne.24677","article-title":"Variations in the proliferative activity of the peripheral retina correlate with postnatal ocular growth in squamate reptiles","volume":"527","author":"Eymann","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100825","article-title":"Age-related macular degeneration: a two-level model hypothesis","author":"Rozing","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/opo.12675","article-title":"Risk factors for progression of age-related macular degeneration","volume":"40","author":"Heesterbeek","year":"2020","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0161-6420(83)34588-7","article-title":"The classification of retinal detachment with proliferative vitreoretinopathy","volume":"90","author":"Hilton","year":"1983","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1350-9462(97)00007-4","article-title":"Risk factors for proliferative vitreoretinopathy","volume":"17","author":"Nagasaki","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1350-9462(01)00023-4","article-title":"Proliferative vitreoretinopathy: risk factors and pathobiology","volume":"21","author":"Pastor","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative vitreoretinopathy: a review","volume":"59","author":"Idrees","year":"2019","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0130","series-title":"Proliferative Vitreoretinopathy, Second Edi","author":"Guidry","year":"2010"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(89)32821-1","article-title":"Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group","volume":"96","author":"Lean","year":"1989","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"M\u00fcller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0145","first-page":"246","article-title":"A brief review of the histopathology of proliferative vitreoretinopathy (PVR)","volume":"342","author":"Mudhar","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0150","article-title":"Retinopathy in diabetes","volume":"27 Suppl 1","author":"Fong","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.040_bb0155","article-title":"Deep learning algorithm predicts diabetic retinopathy progression in individual patients","volume":"21","author":"Arcadu","year":"2019","journal-title":"Npj Digit. Med."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0160","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group - PubMed, (n.d.)."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0165","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2014.07.019","article-title":"The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the action to control cardiovascular risk in diabetes (ACCORD) eye study","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0170","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2337\/dc16-0024","article-title":"Persistent effects of intensive glycemic control on retinopathy in type 2 diabetes in the action to control cardiovascular risk in diabetes (ACCORD) follow-on study","volume":"39","author":"Chew","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0175","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00125-002-0990-7","article-title":"Diabetic retinopathy","volume":"45","author":"Porta","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/exer.2000.0882","article-title":"Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes","volume":"71","author":"Naruse","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100919","article-title":"Photoreceptor cells and RPE contribute to the development of diabetic retinopathy","volume":"83","author":"Tonade","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0190","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-1326.2007.00795.x","article-title":"Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy","volume":"10","author":"E. S, C. I, E. A, S. A, L. CW","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(18)30128-1","article-title":"Incidence and progression of diabetic retinopathy: a systematic review","volume":"7","author":"Sabanayagam","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0205","first-page":"28","article-title":"Diabetic macular edema: current understanding, pharmacologic treatment options, and developing therapies","volume":"7","author":"Miller","year":"2018","journal-title":"Asia-Pacific J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: Beyond the surface","volume":"63","author":"Daruich","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0215","series-title":"Expert Opinion on Pharmacotherapy Pharmacotherapeutic Management of Macular Edema in Diabetic Subjects Undergoing Cataract Surgery Pharmacotherapeutic Management of Macular Edema in Diabetic Subjects Undergoing Cataract Surgery","author":"Sarao","year":"2018"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0220","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjo.81.4.274","article-title":"Retinal vessel dilatation and elongation precedes diabetic macular oedema","volume":"81","author":"Kristinsson","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.eye.6703022","article-title":"Changes in diabetic macular oedema after phacoemulsification surgery","volume":"23","author":"Hayashi","year":"2009","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.visres.2017.06.015","article-title":"Novel therapeutic targets in diabetic macular edema: Beyond VEGF","volume":"139","author":"Urias","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6654168","article-title":"Intravitreal therapy for diabetic macular edema: an update","volume":"2021","author":"Furino","year":"2021","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000365487","article-title":"Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"53","author":"Sakurada","year":"2015","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0245","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.diabres.2007.10.018","article-title":"Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy","volume":"79","author":"Kakehashi","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0250","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2001-15122","article-title":"Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy","volume":"33","author":"Endo","year":"2001","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-030-16638-0_3","article-title":"Optical coherence tomography (OCT): principle and technical realization","author":"Aumann","year":"2019","journal-title":"High Resolut. Imaging Microsc. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0260","doi-asserted-by":"crossref","first-page":"OCT1","DOI":"10.1167\/iovs.16-19963","article-title":"The development, commercialization, and impact of optical coherence tomography","volume":"57","author":"Fujimoto","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0265","article-title":"Optical coherence angiography: a review","volume":"95","author":"Wyl\u0229ga\u0142a","year":"2016","journal-title":"Med. (United States)."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0161-6420(95)31032-9","article-title":"Imaging of macular diseases with optical coherence tomography","volume":"102","author":"Puliafito","year":"1995","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0275","first-page":"78","article-title":"Handbook of optical coherence tomography ophthalmic surgery","volume":"34","author":"Huang","year":"2003","journal-title":"Lasers Imaging Retin."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/01658107.2019.1604764","article-title":"The utility of fundus fluorescein angiography in neuro-ophthalmology","volume":"43","author":"Littlewood","year":"2019","journal-title":"Neuro-Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0285","series-title":"L. Yannuzzi, Fluorescein and ICG Angiography: Textbook and Atlas, Undefined","author":"Richard","year":"1998"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0290","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2147\/OPTH.S133637","article-title":"Ultra-wide-field fluorescein angiography in diabetic retinopathy: a narrative review","volume":"11","author":"Rabiolo","year":"2017","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.jconrel.2022.08.040_bb0295","first-page":"1","article-title":"Selective and complementary use of optical coherence tomography and fluorescein angiography in retinal practice","volume":"31","author":"Shoughy","year":"2016","journal-title":"Eye Vis."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0300","series-title":"Fluorescein Angiography, StatPearls","author":"Ruia","year":"2021"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0305","first-page":"145","article-title":"Video fluorescein angiography: method and clinical application, Graefe\u2019s Arch","volume":"227","author":"Wolf","year":"1989","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0310","first-page":"33","article-title":"Graefes archiv ophthalmologie","volume":"3347","author":"Street","year":"1978","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0315","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.survophthal.2019.02.004","article-title":"Adverse reactions to fluorescein angiography: a comprehensive review of the literature","volume":"64","author":"Kornblau","year":"2019","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0320","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archopht.1988.01060130788004","article-title":"Fluorescein elimination in human breast milk","volume":"106","author":"Maquire","year":"1988","journal-title":"Arch. Ophthalmol. (Chicago, Ill. 1960)"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0325","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/opo.12293","article-title":"Using magnetic resonance imaging to assess visual deficits: a review","volume":"36","author":"Brown","year":"2016","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0330","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/IJG.0000000000001558","article-title":"Magnetic resonance imaging for glaucoma evaluation","volume":"29","author":"Gracitelli","year":"2020","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0335","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neubiorev.2006.06.003","article-title":"Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging","volume":"30","author":"Wozniak","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0340","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jceh.2015.08.001","article-title":"Magnetic resonance imaging: principles and techniques: lessons for clinicians","volume":"5","author":"Grover","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nec.2010.12.004","article-title":"An introduction to diffusion tensor image analysis","volume":"22","author":"O\u2019Donnell","year":"2011","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0350","unstructured":"Physics of MRI, (n.d.)."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0355","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9394(02)02003-2","article-title":"Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography","volume":"135","author":"Kanamori","year":"2003","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0360","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archopht.1995.01100020050027","article-title":"Magnetic resonance imaging in patients with low-tension glaucoma","volume":"113","author":"Stroman","year":"1995","journal-title":"Arch. Ophthalmol. (Chicago, Ill. 1960)"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0365","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.sjopt.2014.02.008","article-title":"Retinal imaging in uveitis","volume":"28","author":"Gupta","year":"2014","journal-title":"Saudi J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0370","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/NRL.0b013e318272f7d7","article-title":"The use of retinal photography in non-ophthalmic settings and its potential for neurology","volume":"18","author":"P\u00e9rez","year":"2012","journal-title":"Neurologist."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0375","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0974-9233.151887","article-title":"Imaging in diabetic retinopathy","volume":"22","author":"Salz","year":"2015","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0380","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.joco.2016.04.001","article-title":"Ultra-wide-field imaging in diabetic retinopathy; an overview","volume":"28","author":"Ghasemi Falavarjani","year":"2016","journal-title":"J. Curr. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0385","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41433-020-01262-7","article-title":"Review of retinal cameras for global coverage of diabetic retinopathy screening","volume":"35","author":"Rajalakshmi","year":"2021","journal-title":"Eye."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0390","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/01658107.2013.773451","article-title":"Non-mydriatic ocular fundus photography and telemedicine: past, present, and future","volume":"37","author":"Bruce","year":"2013","journal-title":"Neuro-Ophthalmology"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0395","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ophtha.2004.02.004","article-title":"Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology","volume":"111","author":"Williams","year":"2004","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0400","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1932296816629491","article-title":"Retinal imaging techniques for diabetic retinopathy screening","volume":"10","author":"Goh","year":"2016","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0405","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/0301-4738.154407","article-title":"Regarding fundus imaging with a mobile phone: a review of techniques","volume":"63","author":"Raju","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40942-021-00313-9","article-title":"Smartphone fundus photography: a narrative review","volume":"7","author":"Iqbal","year":"2021","journal-title":"Int. J. Retin. Vitr."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3801570","article-title":"Ocular complications of diabetes and therapeutic approaches","volume":"2016","author":"Vieira-Potter","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0420","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0425","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/jovr.jovr_50_18","article-title":"Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: clinical practice guideline","volume":"13","author":"Nikkhah","year":"2018","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0430","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics10010028","article-title":"Ocular drug delivery barriers\u2014role of nanocarriers in the treatment of anterior segment ocular diseases","volume":"10","author":"Bachu","year":"2018","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0435","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pharmaceutics13010036","article-title":"Therapeutic ophthalmic lenses: a review","volume":"13","author":"Toffoletto","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0440","first-page":"235","article-title":"Anti-vascular endothelial growth factor indications in ocular disease","volume":"59","author":"Cornel","year":"2015","journal-title":"Rom. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0445","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0450","first-page":"44","article-title":"Anti-VEGF drugs in the prevention of blindness","volume":"27","author":"Yorston","year":"2014","journal-title":"Community Eye Heal."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0455","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0460","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1023\/A:1023238530504","article-title":"Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers","volume":"20","author":"Pitk\u00e4nen","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0465","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1167\/iovs.05-0165","article-title":"Vitreous: a barrier to nonviral ocular gene therapy","volume":"46","author":"Peeters","year":"2005","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0470","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0475","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1167\/iovs.03-0959","article-title":"Ophthalmic drug delivery through contact lenses","volume":"45","author":"Gulsen","year":"2004","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0480","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0485","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jconrel.2012.01.019","article-title":"Liposomes for intravitreal drug delivery: a state of the art","volume":"161","author":"Bochot","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0490","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.addr.2006.07.026","article-title":"Intraocular implants for extended drug delivery: therapeutic applications","volume":"58","author":"Bourges","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0495","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems. a shift to the posterior segment","volume":"13","author":"del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0500","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2012.0200","article-title":"Novel strategies for anterior segment ocular drug delivery","volume":"29","author":"Cholkar","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0505","article-title":"Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma","author":"Kompella","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0510","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.4.4.371","article-title":"Novel approaches to retinal drug delivery","volume":"4","author":"Janoria","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0515","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0520","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.preteyeres.2010.04.004","article-title":"Nanoparticles for retinal gene therapy Shannon","volume":"29","author":"C","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0525","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.ophtha.2003.08.020","article-title":"Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes","volume":"110","author":"Slaker","year":"2003","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0530","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4155\/tde-2017-0097","article-title":"Posterior drug delivery via periocular route: challenges and opportunities","volume":"8","author":"Waite","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0535","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1167\/iovs.07-0593","article-title":"Modeling of corneal and retinal pharmacokinetics after periocular drug administration","volume":"49","author":"Amrite","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0540","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2020.12.015","article-title":"Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: current advancement and future breakthroughs","volume":"330","author":"Dhas","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0545","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2021.03.021","article-title":"Stimuli responsive and receptor targeted iron oxide based nanoplatforms for multimodal therapy and imaging of cancer: conjugation chemistry and alternative therapeutic strategies","volume":"333","author":"Dhas","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0550","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/bja\/aeg105","article-title":"Sub-Tenon\u2019s administration of local anaesthetic: a review of the technique","volume":"90","author":"Canavan","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0555","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/LRA.S16314","article-title":"Sub-Tenon\u2019s anesthesia: an update, local","volume":"5","author":"Guise","year":"2012","journal-title":"Reg. Anesth."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0560","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/ICO.0000000000000192","article-title":"Intrastromal antifungal injection with secondary lamellar interface infusion for late-onset infectious keratitis after DSAEK","volume":"33","author":"Tu","year":"2014","journal-title":"Cornea."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0565","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jtos.2019.08.001","article-title":"Infectious interface keratitis (IIK) following lamellar keratoplasty: a literature review","volume":"17","author":"Gao","year":"2019","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0570","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jcrs.2011.03.005","article-title":"Intrastromal injection of antibiotic agent in the management of recalcitrant bacterial keratitis","volume":"37","author":"Liang","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2008.02.023","article-title":"Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis","volume":"146","author":"Prakash","year":"2008","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0580","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1136\/bjo.2010.192815","article-title":"Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series","volume":"95","author":"Sharma","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0585","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0161-6420(01)00793-X","article-title":"Intracameral anesthesia","volume":"108","author":"Karp","year":"2001","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0590","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/10807680152729257","article-title":"Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection","volume":"17","author":"Lee","year":"2001","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0595","first-page":"233","article-title":"Hydrostatic pressure of the suprachoroidal space","volume":"30","author":"Emi","year":"1989","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0600","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jbiomech.2007.11.010","article-title":"Finite element simulation of arcuates for astigmatism correction","volume":"41","author":"Lanchares","year":"2008","journal-title":"J. Biomech."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0605","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0420.1997.tb00244.x","article-title":"Corrosion casts of the suprachoroidal space and uveoscleral drainage routes in the pig eye","volume":"75","author":"Krohn","year":"1997","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0610","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.exer.2008.12.012","article-title":"Uveoscleral outflow - A review","volume":"88","author":"Alm","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0048188","article-title":"Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry","volume":"7","author":"Tyagi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0620","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1167\/iovs.10-6291","article-title":"Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model","volume":"52","author":"Olsen","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0625","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1167\/iovs.17-23758","article-title":"Targeted drug delivery in the suprachoroidal space by swollen hydrogel pushing","volume":"59","author":"Jung","year":"2018","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0630","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.drudis.2019.03.027","article-title":"Targeting drug delivery within the suprachoroidal space","volume":"24","author":"Jung","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0635","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.drudis.2019.05.031","article-title":"Recent advances in intraocular sustained-release drug delivery devices","volume":"24","author":"Cao","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0640","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijbiomac.2019.10.256","article-title":"Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: a potential topical treatment for posterior segment diseases","volume":"143","author":"Khalil","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0645","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","article-title":"Barriers to glaucoma drug delivery","volume":"17","author":"Ghate","year":"2008","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0650","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.bioeng.6.040803.140055","article-title":"Ocular biomechanics and biotransport","volume":"6","author":"Ethier","year":"2004","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0655","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.2015.0047","article-title":"Recent advances in topical ocular drug delivery","volume":"32","author":"Yellepeddi","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0660","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0665","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/10611860400015910","article-title":"Cationic vectors in ocular drug delivery","volume":"12","author":"Rabinovich-Guilatt","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0670","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/17425247.2014.935338","article-title":"Advances in ocular drug delivery: emphasis on the posterior segment","volume":"11","author":"Kang-Mieler","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0675","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/mt.2009.181","article-title":"Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous","volume":"17","author":"Dalkara","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0680","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/DDC-120003445","article-title":"Ocular preparations: the formulation approach","volume":"28","author":"Kaur","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0685","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/08820538.2014.962167","article-title":"Complications of intravitreal injections in patients with diabetes","volume":"29","author":"Shikari","year":"2014","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0690","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2014.09.030","article-title":"Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems","volume":"196","author":"Yasin","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0695","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1111\/aos.14014","article-title":"Irrigating the eye after intravitreal injection reduces epithelial damage but not patient discomfort","volume":"97","author":"Jandorf","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0700","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jconrel.2020.07.031","article-title":"Intravitreal hydrogels for sustained release of therapeutic proteins","volume":"326","author":"Ilochonwu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0705","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jconrel.2021.03.035","article-title":"Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models","volume":"333","author":"Rebibo","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0710","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.9.8.28","article-title":"Intravitreal injection with a conjunctival injection device: a single-center experience","volume":"9","author":"Soh","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0715","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/adma.200400719","article-title":"Electrospinning of nanofibers: reinventing the wheel?","volume":"16","author":"Li","year":"2004","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0720","series-title":"Nano-Size Polym.","first-page":"309","article-title":"Electrospinning\u2014commercial applications, challenges and opportunities","author":"Kannan","year":"2016"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0725","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejps.2017.07.001","article-title":"Electrospun polymeric nanofibers: new horizons in drug delivery","volume":"107","author":"Thakkar","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0730","doi-asserted-by":"crossref","DOI":"10.5731\/pdajpst.2019.011403","article-title":"Hot Melt extrusion: An emerging technique for solubility enhancement of poorly water soluble drugs","author":"Chivate","year":"2021","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0735","doi-asserted-by":"crossref","DOI":"10.1039\/D1NJ04159B","article-title":"Electrospinning nanofiber technology: a multifaceted paradigm in biomedical applications","author":"Garkal","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0740","article-title":"Solvent effects on the elasticity of electrospinnable polymer solutions","author":"Ewaldz","year":"2021","journal-title":"ACS Polym. Au."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.polymertesting.2020.106647","article-title":"A review on electrospun polymeric nanofibers: production parameters and potential applications","volume":"90","author":"Ibrahim","year":"2020","journal-title":"Polym. Test."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0750","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/21691401.2016.1185726","article-title":"Drug loading and delivery using nanofibers scaffolds","volume":"45","author":"Mohammadian","year":"2017","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0755","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/pharmaceutics13101637","article-title":"A systematic review of drug-loaded electrospun nanofiber-based ophthalmic inserts","volume":"13","author":"Omer","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0760","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.addr.2019.10.006","article-title":"Nanotechnology in regenerative ophthalmology","volume":"148","author":"Sahle","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0765","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.actbio.2017.10.015","article-title":"Electrospun formulations of bevacizumab for sustained release in the eye","volume":"64","author":"Angkawinitwong","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0770","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jconrel.2020.01.036","article-title":"Injectable biodegradable bi-layered capsule for sustained delivery of bevacizumab in treating wet age-related macular degeneration","volume":"320","author":"Jiang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0775","first-page":"1242","article-title":"Protein- and peptide-based electrospun nanofibers in medical biomaterials, Nanomedicine Nanotechnology","volume":"8","author":"Khadka","year":"2012","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0780","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17425247.2019.1660318","article-title":"Shaping the future: recent advances of 3D printing in drug delivery and healthcare","volume":"16","author":"Trenfield","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120330","article-title":"3D printed polymeric drug-eluting implants","volume":"597","author":"Liaskoni","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0790","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.drudis.2019.04.009","article-title":"Retinal cell regeneration using tissue engineered polymeric scaffolds","volume":"24","author":"Abedin Zadeh","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0795","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5530\/ijpi.2020.3.43","article-title":"Three dimensional printing by hot-melt extrusion; new era for development of personalized medicines and continuous manufacturing of pharmaceuticals","volume":"10","author":"Chivate","year":"2020","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0800","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.actbio.2020.09.015","article-title":"3D printing of drug-loaded multi-shell rods for local delivery of bevacizumab and dexamethasone: a synergetic therapy for retinal vascular diseases","volume":"116","author":"Won","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121010","article-title":"3D printed ocusert laden with ultra-fluidic glycerosomes of ganciclovir for the management of ocular cytomegalovirus retinitis","volume":"607","author":"Naguib","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0810","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1039\/c0lc00013b","article-title":"A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery","volume":"10","author":"Fine","year":"2010","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0815","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1021\/nl302747y","article-title":"Nanostructured thin film polymer devices for constant-rate protein delivery","volume":"12","author":"Bernards","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0820","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s13346-016-0298-7","article-title":"In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device","volume":"6","author":"Lance","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0825","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/btm2.10121","article-title":"Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery","volume":"4","author":"Schlesinger","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0830","first-page":"559","article-title":"Thin films as an emerging platform for drug delivery","volume":"11","author":"Karki","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0835","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/jop.2012.0152","article-title":"Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films","volume":"29","author":"Bernards","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0840","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0167-7799(02)02037-1","article-title":"Encapsulated cell technology: from research to market","volume":"20","author":"Orive","year":"2002","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0845","doi-asserted-by":"crossref","unstructured":"W. Tao, R. Wen, Application of encapsulated cell technology for retinal degenerative diseases, in: Retin. Degener., Humana Press, Totowa, NJ, n.d.: pp. 401\u2013413. doi: https:\/\/doi.org\/10.1007\/978-1-59745-186-4_21.","DOI":"10.1007\/978-1-59745-186-4_21"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0850","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14712598.6.7.717","article-title":"Application of encapsulated cell technology for retinal degenerative diseases","volume":"6","author":"Tao","year":"2006","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0855","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejpb.2014.10.005","article-title":"Encapsulated cells for long-term secretion of soluble VEGF receptor 1: material optimization and simulation of ocular drug response","volume":"95","author":"Kontturi","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0860","doi-asserted-by":"crossref","DOI":"10.3791\/60162","article-title":"Encapsulated cell technology for the delivery of biologics to the mouse eye","author":"Belhaj","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0865","series-title":"Controlled Drug Delivery","author":"Vyas","year":"2006"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0870","series-title":"The Theory and Practice of Industrial Pharmacy - ScienceDirect","author":"Lieberman","year":"2007"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0875","doi-asserted-by":"crossref","DOI":"10.1089\/jop.2016.0025","article-title":"Pharmacokinetic studies of sustained-release depot of dexamethasone in beagle dogs","author":"Blizzard","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0880","article-title":"Minimally invasive microneedles for ocular drug delivery","author":"Singh","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116907","article-title":"Applications of microneedles in delivering drugs for various ocular diseases","volume":"237","author":"Gupta","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0890","first-page":"1","article-title":"A key role by polymers in microneedle technology: a new era, Drug Dev","author":"Rajput","year":"2022","journal-title":"Ind. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06981-w","article-title":"Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery","volume":"9","author":"Than","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0900","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejpb.2021.05.022","article-title":"Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye","volume":"165","author":"Wu","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0905","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2018.03.001","article-title":"Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle","volume":"277","author":"Jung","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0910","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000438969","article-title":"Neovascular age-related macular degeneration","volume":"55","author":"Shao","year":"2015","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0915","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/17425247.2021.1968826","article-title":"Port delivery system: a novel drug delivery platform to treat retinal diseases","volume":"18","author":"Khanani","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0920","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2147\/OPTH.S194234","article-title":"Therapeutic potential of the ranibizumab port delivery system in the treatment of amd: evidence to date","volume":"14","author":"Chen","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0925","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.oret.2020.11.004","article-title":"End-of-study results for the ladder phase 2 trial of the port delivery system with ranibizumab for neovascular age-related macular degeneration","volume":"5","author":"Khanani","year":"2021","journal-title":"Ophthalmol. Retin."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0930","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","article-title":"The port delivery system with ranibizumab for neovascular age-related macular degeneration","volume":"126","author":"Campochiaro","year":"2019","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0935","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/psc.2672","article-title":"Cell penetration: scope and limitations by the application of cell-penetrating peptides","volume":"20","author":"Reissmann","year":"2014","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0940","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0945","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1167\/iovs.16-20072","article-title":"Topical delivery of anti-VEGF drugs to the ocular posterior segment using cell-penetrating peptides","volume":"58","author":"de Cogan","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0950","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.mt.6300324","article-title":"Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea leslie","volume":"16","author":"Johnson","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0955","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41434-019-0100-9","article-title":"Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat","volume":"26","author":"Dias","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0960","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.omtn.2017.06.004","article-title":"Reducible PEG-POD\/DNA nanoparticles for gene transfer in vitro and in vivo: application in a mouse model of age-related macular degeneration","volume":"8","author":"Dasari","year":"2017","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0965","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/jop.2014.0019","article-title":"Subconjunctival injection of XG-102, a c-Jun N-terminal kinase inhibitor peptide, in the treatment of endotoxin-induced uveitis in rats","volume":"31","author":"El Zaoui","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0970","doi-asserted-by":"crossref","first-page":"19256","DOI":"10.1021\/acsami.6b04551","article-title":"Facile noninvasive retinal gene delivery enabled by penetratin","volume":"8","author":"Liu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0975","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2018.06.023","article-title":"Cell penetrating peptides in ocular drug delivery: state of the art","volume":"284","author":"Pescina","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0980","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2018.06.023","article-title":"Cell penetrating peptides in ocular drug delivery: state of the art","volume":"284","author":"Pescina","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb0985","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0990","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.preteyeres.2004.02.003","article-title":"Drug delivery systems for vitreoretinal diseases","volume":"23","author":"Yasukawa","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb0995","article-title":"Nanoparticulate transscleral ocular drug delivery","volume":"03","author":"S.","year":"2014","journal-title":"J. Biomol. Res. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1000","first-page":"65","article-title":"Microencapsulation: a promising technique for controlled drug delivery","volume":"5","author":"Singh","year":"2010","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000455276","article-title":"Drug delivery to the posterior segment of the eye","volume":"58","author":"Moisseiev","year":"2017","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/02713689408995774","article-title":"Feasibility of drug targeting to the retinal pigment epithelium with biodegradable microspheres","volume":"13","author":"Moritera","year":"1994","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1020","series-title":"Biodegradable Polymers for the, Source Sci. New Ser","first-page":"803","volume":"297","author":"Kimura","year":"2002"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biomaterials.2017.02.006","article-title":"Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats","volume":"124","author":"Peters","year":"2017","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1030","doi-asserted-by":"crossref","unstructured":"A.E. Azab, S.A. Ebrahim, Saudi Journal of Biomedical Research Exposure to Electromagnetic Fields Induces Pathophysiological Changes and Oxidative Stress in the Cardiovascular System, (n.d.) 96\u2013100. doi: 10.21276\/sjbr.","DOI":"10.21276\/sjbr"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2165\/00002512-200724070-00006","article-title":"Sustained-release ophthalmic drug delivery systems for treatment of macular disorders","volume":"24","author":"Booth","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2005.02.019","article-title":"Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model","volume":"511","author":"Ayalasomayajula","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2015.05.279","article-title":"Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology","volume":"211","author":"Andr\u00e9s-Guerrero","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1050","first-page":"305","article-title":"Biodegradable microspheres containing heparin in the treatment of proliferative vitreoretinopathy","volume":"18","author":"Liu","year":"2000","journal-title":"Chin. Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1167\/iovs.01-1156","article-title":"Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres","volume":"44","author":"Carrasquillo","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejpb.2003.10.018","article-title":"PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification\/spray-drying as the preparation method: in vitro\/in vivo studies","volume":"57","author":"Gavini","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1065","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3109\/02713683.2015.1101140","article-title":"Controlled and extended in vitro release of bioactive anti-vascular endothelial growth factors from a microsphere-hydrogel drug delivery system","volume":"41","author":"Osswald","year":"2016","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2010.05.011","article-title":"Issues in long-term protein delivery using biodegradable microparticles","volume":"146","author":"Ye","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2015.04.075","article-title":"Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles","volume":"489","author":"Vaishya","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1874364101206010054","article-title":"Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration","volume":"6","author":"Li","year":"2012","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1085","first-page":"653","article-title":"Pharmacokinetics and distributions of bevacizumab by intravitreal injection of bevacizumab- PLGA microspheres in rabbits","volume":"8","author":"Ye","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(03)00087-5","article-title":"Bioadhesive microspheres as a controlled drug delivery system","volume":"255","author":"Vasir","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0975-7406.76478","article-title":"Mucoadhesive drug delivery systems","volume":"3","author":"Shaikh","year":"2011","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1100","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.2042-7158.1997.tb06103.x","article-title":"Bioadhesive microspheres for ophthalmic administration of acyclovir","volume":"49","author":"Genta","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-5173(00)00671-2","article-title":"Gel-forming erodible inserts for ocular controlled delivery of ofloxacin","volume":"215","author":"Di Colo","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2006.01.004","article-title":"Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport","volume":"64","author":"Zambito","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1115","series-title":"Bye Research","first-page":"563","volume":"8","author":"Edman","year":"1989"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/9781119640240.ch7","article-title":"Ocular Bioadhesive Drug Delivery Systems and Their Applications","author":"Sharma","year":"2020","journal-title":"Bioadhesives Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1125","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4103\/1673-5374.143410","article-title":"Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson\u2019s disease","volume":"9","author":"Hegarty","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/aem.43.5.1086-1091.1982","article-title":"Agar-like polysaccharide produced by a pseudomonas species: production and basic properties","volume":"43","author":"Kang","year":"1982","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1135","first-page":"251","article-title":"In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin","volume":"53","author":"Balasubramaniam","year":"2003","journal-title":"Acta Pharma."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/nano10040709","article-title":"In vitro and ex vivo evaluation of nepafenac-based cyclodextrin microparticles for treatment of eye inflammation","volume":"10","author":"Lorenzo-Veiga","year":"2020","journal-title":"Nanomaterials."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S2221-6189(13)60087-6","article-title":"Magnetic microspheres as magical novel drug delivery system: a review","volume":"2","author":"Kakar","year":"2013","journal-title":"J. Acute Dis."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep43092","article-title":"Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye","volume":"7","author":"Giannaccini","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1155","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.3390\/ijms22094404","article-title":"Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye","volume":"22","author":"Santonocito","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1160","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.drudis.2019.05.037","article-title":"Hydrogels for sustained delivery of biologics to the back of the eye","volume":"24","author":"Chang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1165","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1021\/cr200157d","article-title":"Hydrogels for protein delivery","volume":"112","author":"Vermonden","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1170","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1175","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/acs.molpharmaceut.7b00067","article-title":"Bio-orthogonal cross-linking chemistry enables in situ protein encapsulation and provides sustained release from hyaluronic acid based hydrogels","volume":"14","author":"Famili","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2018.11.012","article-title":"Controlled release strategy designed for intravitreal protein delivery to the retina","volume":"293","author":"Delplace","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2019.01.007","article-title":"Long-acting intraocular delivery strategies for biological therapy of age-related macular degeneration","volume":"296","author":"Iyer","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eurpolymj.2017.12.004","article-title":"Recent advances in smart hydrogels for biomedical applications: From self-assembly to functional approaches","volume":"99","author":"Ferreira","year":"2018","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1195","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1039\/C6CS00052E","article-title":"Hydrogel scaffolds for differentiation of adipose-derived stem cells","volume":"46","author":"Huang","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/rb\/rbz022","article-title":"Advances of injectable hydrogel-based scaffolds for cartilage regeneration","volume":"6","author":"Li","year":"2019","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/rb\/rbz027","article-title":"Enhanced angiogenesis by the hyaluronic acid hydrogels immobilized with a VEGF mimetic peptide in a traumatic brain injury model in rats","volume":"6","author":"Lu","year":"2019","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rb\/rbz039","article-title":"Platelet-rich plasma combined with injectable hyaluronic acid hydrogel for porcine cartilage regeneration: a 6-month follow-up","volume":"7","author":"Yan","year":"2019","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.actbio.2020.07.033","article-title":"Body temperature-activated protein-based injectable adhesive hydrogel incorporated with decellularized adipose extracellular matrix for tissue-specific regenerative stem cell therapy","volume":"114","author":"Jeon","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.actbio.2020.04.003","article-title":"Redox injectable gel protects osteoblastic function against oxidative stress and suppresses alveolar bone loss in a rat peri-implantitis model","volume":"110","author":"Ozawa","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.actbio.2020.09.013","article-title":"An injectable click-crosslinked hyaluronic acid hydrogel modified with a BMP-2 mimetic peptide as a bone tissue engineering scaffold","volume":"117","author":"Park","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actbio.2020.03.039","article-title":"A moldable thermosensitive hydroxypropyl chitin hydrogel for 3D cartilage regeneration in vitro and in vivo","volume":"108","author":"Xu","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1235","doi-asserted-by":"crossref","first-page":"2001404","DOI":"10.1002\/adhm.202001404","article-title":"Cell-free bilayered porous scaffolds for osteochondral regeneration fabricated by continuous 3d-printing using nascent physical hydrogel as ink","volume":"10","author":"Gao","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1240","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1016\/j.biomaterials.2014.05.064","article-title":"Release behavior and intra-articular biocompatibility of celecoxib-loaded acetyl-capped PCLA-PEG-PCLA thermogels","volume":"35","author":"Petit","year":"2014","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1245","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/acs.biomac.6b01604","article-title":"Hydrogels for therapeutic delivery: current developments and future directions","volume":"18","author":"Buwalda","year":"2017","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.actbio.2019.07.024","article-title":"An injectable thermosensitive photothermal-network hydrogel for near-infrared-triggered drug delivery and synergistic photothermal-chemotherapy","volume":"96","author":"Liu","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1255","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2019.01.001","article-title":"An injectable and thermosensitive hydrogel: promoting periodontal regeneration by controlled-release of aspirin and erythropoietin","volume":"86","author":"Xu","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1260","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.actbio.2020.09.018","article-title":"Antimicrobial and anti-inflammatory thermo-reversible hydrogel for periodontal delivery","volume":"116","author":"Wang","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biomaterials.2018.08.044","article-title":"Antibacterial adhesive injectable hydrogels with rapid self-healing, extensibility and compressibility as wound dressing for joints skin wound healing","volume":"183","author":"Qu","year":"2018","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.actbio.2020.06.006","article-title":"Drug-impregnated, pressurized gas expanded liquid-processed alginate hydrogel scaffolds for accelerated burn wound healing","volume":"112","author":"Johnson","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1275","series-title":"Proc. 2019 9th Int. Work. Comput. Sci. Eng","first-page":"99","article-title":"Multi-objective optimization recommendation algorithm based on collaborative filtering and item similarity","volume":"2019","author":"Zhao","year":"2020"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1280","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.actbio.2016.02.028","article-title":"Thermosensitive injectable in-situ forming carboxymethyl chitin hydrogel for three-dimensional cell culture","volume":"35","author":"Liu","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biomaterials.2018.01.001","article-title":"Injectable thermogel for 3D culture of stem cells","volume":"159","author":"Patel","year":"2018","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1290","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s13770-018-0148-4","article-title":"Polypeptide thermogels as three-dimensional scaffolds for cells","volume":"15","author":"Patel","year":"2018","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1295","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/rb\/rbaa018","article-title":"Investigating materials and orientation parameters for the creation of a 3D musculoskeletal interface co-culture model","volume":"7","author":"Alsaykhan","year":"2020","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2021.04.009","article-title":"PEG-based thermosensitive and biodegradable hydrogels","author":"Shi","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.addr.2021.04.007","article-title":"Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and associated fibrosis","volume":"173","author":"Silva","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1310","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.carbpol.2016.02.080","article-title":"Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment","volume":"144","author":"Cheng","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1315","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2016.02.027","article-title":"V Khutoryanskiy, In situ gelling systems based on Pluronic F127\/Pluronic F68 formulations for ocular drug delivery","volume":"502","author":"Al Khateb","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1320","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/17425247.2012.665367","article-title":"In situ gel systems as \u2018smart\u2019 carriers for sustained ocular drug delivery","volume":"9","author":"Agrawal","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.dyepig.2011.11.002","article-title":"Performance improvement of dye-sensitizing solar cell by semi-rigid triarylamine-based donors","volume":"94","author":"Wang","year":"2012","journal-title":"Dyes Pigments"},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2022.08.040_bb1330","first-page":"19","article-title":"Stimuli-sensitive hydrogels in controlled and sustained drug delivery","volume":"39","author":"Masteikov\u00e1","year":"2003","journal-title":"Medicina"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2231-4040.107495","article-title":"Occupational, environmental, and lifestyle factors and their contribution to preterm birth – An overview","volume":"4","author":"Kumar","year":"2013","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2008.01.005","article-title":"In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery","volume":"127","author":"He","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1345","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer (Guildf)."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1350","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1039\/b713009k","article-title":"Injectable hydrogels as unique biomedical materials","volume":"37","author":"Yu","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1355","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/bm200083n","article-title":"Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review","volume":"12","author":"Van Vlierberghe","year":"2011","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1360","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1211\/0022357022476","article-title":"The potential of chitosan in ocular drug delivery","volume":"55","author":"Alonso","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1365","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2174\/138955709791012292","article-title":"Chitosan and its role in ocular therapeutics","volume":"9","author":"Wadhwa","year":"2009","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2009.07.019","article-title":"Chitosan-based hydrogels for controlled, localized drug delivery","volume":"62","author":"Bhattarai","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118688","article-title":"Thermosensitive glycol chitosan-based hydrogel as a topical ocular drug delivery system for enhanced ocular bioavailability","volume":"570","author":"Shi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msec.2018.02.022","article-title":"In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery","volume":"88","author":"Song","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1385","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1021192711007","article-title":"A comparative study on chemical conversion of cellulose between the batch-type and flow-type systems in supercritical water","volume":"9","author":"Ehara","year":"2002","journal-title":"Cellulose."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1390","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0001-8686(02)00035-0","article-title":"Synthesis and general properties of silated-hydroxypropyl methylcellulose in prospect of biomedical use","volume":"99","author":"Bourges","year":"2002","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1395","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1021\/bm700446p","article-title":"Synthesis of thermally stable carboxymethyl cellulose\/metal biodegradable nanocomposites for potential biological applications","volume":"8","author":"Nadagouda","year":"2007","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1400","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10853-015-9382-5","article-title":"A review of hydrogel-based composites for biomedical applications: enhancement of hydrogel properties by addition of rigid inorganic fillers","volume":"51","author":"Utech","year":"2016","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","article-title":"In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate","volume":"241","author":"El-Kamel","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1410","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1359-6446(02)02444-3","article-title":"Therapeutic synthetic polymers: a game of Russian roulette?","volume":"7","author":"Hunter","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1415","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1420","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/js970090e","article-title":"In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine","volume":"87","author":"Desai","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1425","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/03639040500214688","article-title":"Release of ciprofloxacin from chondroitin 6-sulfate-graft-poloxamer hydrogel in vitro for ophthalmic drug delivery","volume":"31","author":"Yoo","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1430","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2013.03.024","article-title":"Development and evaluation of fast forming nano-composite hydrogel for ocular delivery of diclofenac","volume":"448","author":"Li","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1435","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2017.01.008","article-title":"Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterisation, toxicity and transcorneal permeation studies","volume":"114","author":"Fathalla","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1440","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/0929867311302010009","article-title":"Thermosensitive polymeric hydrogels as drug delivery systems","volume":"20","author":"Gong","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1445","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biomaterials.2013.10.016","article-title":"Injectable thermosensitive PEG\u2013PCL\u2013PEG hydrogel\/acellular bone matrix composite for bone regeneration in cranial defects","volume":"35","author":"Ni","year":"2014","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1450","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/jbm.a.35253","article-title":"Thermosensitive block copolymer hydrogels based on poly(\u025b-caprolactone) and polyethylene glycol for biomedical applications: state of the art and future perspectives","volume":"103","author":"Boffito","year":"2015","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1455","doi-asserted-by":"crossref","first-page":"1900001","DOI":"10.1002\/mabi.201900001","article-title":"Stimulus-responsive hydrogel for ophthalmic drug delivery","volume":"19","author":"Lin","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1460","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/DDDT.S293127","article-title":"Development and characterization of PLGA nanoparticle-laden hydrogels for sustained ocular delivery of norfloxacin in the treatment of pseudomonas keratitis: an experimental study","author":"Gebreel","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1465","first-page":"94","article-title":"Gellan gum wins IFT\u2019s food technology industrial achievement award","volume":"47","author":"Pszczola","year":"1993","journal-title":"Food Technol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1470","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(89)90305-0","article-title":"Gelrite\u00ae: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol","volume":"57","author":"Rozier","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1475","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/jps.10371","article-title":"Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups","volume":"92","author":"Krauland","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1480","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-0987(99)00051-2","article-title":"Rheological studies of the gelation of deacetylated gellan gum (Gelrite\u00ae) in physiological conditions","volume":"9","author":"Paulsson","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1485","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2014.03.038","article-title":"Application of gellan gum in pharmacy and medicine","volume":"466","author":"Osma\u0142ek","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1490","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.carbpol.2014.07.021","article-title":"Mucoadhesive beads of gellan gum\/pectin intended to controlled delivery of drugs","volume":"113","author":"Prezotti","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1495","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.foodhyd.2014.07.006","article-title":"Low acyl gellan gum fluid gel formation and their subsequent response with acid to impact on satiety","volume":"43","author":"Bradbeer","year":"2015","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1500","article-title":"Design and evaluation of mucoadhesive in situ liposomal gel for sustained ocular delivery of travoprost using two steps factorial design","volume":"61","author":"Shukr","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1505","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/DDDT.S153405","article-title":"A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation","volume":"12","author":"Sun","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1510","first-page":"3943","article-title":"A novel in situ gel base of deacetylase gellan gum for sustained ophthalmic drug delivery of ketotifen: in vitro and in vivo evaluation","volume":"9","author":"Zhu","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1515","doi-asserted-by":"crossref","first-page":"337","DOI":"10.22270\/jddt.v9i1.2231","article-title":"Ocular in situ gel: an overview","volume":"9","author":"Majeed","year":"2019","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1520","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/2230-973X.100042","article-title":"Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride","volume":"2","author":"Mandal","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248857","article-title":"Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections","volume":"16","author":"Nair","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1530","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/2230-973X.100036","article-title":"Stimuli sensitive hydrogels for ophthalmic drug delivery: a review","volume":"2","author":"Kushwaha","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1535","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.addr.2012.07.007","article-title":"Remote and local control of stimuli responsive materials for therapeutic applications","volume":"65","author":"Chan","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1540","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/biot.201300073","article-title":"Polymer-based stimuli-responsive nanosystems for biomedical applications","volume":"8","author":"Joglekar","year":"2013","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120380","article-title":"Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma","volume":"598","author":"Allam","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1550","article-title":"Development and in-vitro in-vivo characterization of in-situ gelling sustained-release nevirapine suspension","volume":"67","author":"Garkal","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1555","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1560","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/molecules21081002","article-title":"Stimuli-responsive polymeric systems for controlled protein and peptide delivery: future implications for ocular delivery","volume":"21","author":"Mahlumba","year":"2016","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1565","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1038\/s41598-018-20363-8","article-title":"Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy","volume":"8","author":"Bhandari","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1570","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ultrasmedbio.2012.11.010","article-title":"Ultrasound-enhanced delivery of antibiotics and anti-inflammatory drugs into the eye","volume":"39","author":"Nabili","year":"2013","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1575","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/nat.2015.0573","article-title":"Fit for the eye: aptamers in ocular disorders","volume":"26","author":"Drolet","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1580","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chembiol.2004.10.017","article-title":"Direct in vitro selection of a 2\u2032-o-methyl aptamer to VEGF","volume":"12","author":"Burmeister","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1585","doi-asserted-by":"crossref","first-page":"20556","DOI":"10.1074\/jbc.273.32.20556","article-title":"2\u2032-fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165)","volume":"273","author":"Ruckman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1590","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/ijms18081683","article-title":"Chemical modifications of nucleic acid aptamers for therapeutic purposes","volume":"18","author":"Ni","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1595","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pharmtox-010716-104558","article-title":"Aptamers as therapeutics","volume":"57","author":"Nimjee","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1600","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1605","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ophtha.2016.10.010","article-title":"Dual antagonism of PDGF and VEGF in neovascular age-related macular degeneration: a phase IIb, multicenter, randomized controlled trial","volume":"124","author":"Jaffe","year":"2017","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1610","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.gene.2013.12.019","article-title":"Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies","volume":"538","author":"Deng","year":"2014","journal-title":"Gene."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1615","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/adhm.201600418","article-title":"Biomaterials in siRNA delivery: a comprehensive review","volume":"5","author":"Ho","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1620","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICU.0b013e328329b5f2","article-title":"Stem-cell therapy in retinal disease","volume":"20","author":"Baker","year":"2009","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1625","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/ncomms5047","article-title":"Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs","volume":"5","author":"Zhong","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1630","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.stemcr.2014.03.011","article-title":"Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice","volume":"2","author":"Assawachananont","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1635","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13287-020-02122-7","article-title":"Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa","volume":"12","author":"Tuekprakhon","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1640","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/2008-322X.200164","article-title":"Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study","volume":"12","author":"Satarian","year":"2017","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1645","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bios.2019.02.070","article-title":"On-chip anticancer drug screening \u2013 recent progress in microfluidic platforms to address challenges in chemotherapy","volume":"137","author":"Dhiman","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1650","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/mi12111349","article-title":"Microfluidic systems for cancer diagnosis and applications","volume":"12","author":"Akg\u00f6n\u00fcll\u00fc","year":"2021","journal-title":"Micromachines."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1655","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.copbio.2019.11.022","article-title":"Microfluidic systems for cancer diagnostics","volume":"65","author":"Garcia-Cordero","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1660","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12575-022-00166-y","article-title":"Recent advances for cancer detection and treatment by microfluidic technology, review and update","volume":"24","author":"Bargahi","year":"2022","journal-title":"Biol. Proced. Online."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1665","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1038\/s41467-022-30384-7","article-title":"A role for microfluidic systems in precision medicine","volume":"13","author":"Ayuso","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1670","doi-asserted-by":"crossref","first-page":"ORSFd1","DOI":"10.1167\/iovs.16-19127","article-title":"Stem cell sources and their potential for the treatment of retinal degenerations","volume":"57","author":"Canto-Soler","year":"2016","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1675","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/jbm.a.36424","article-title":"Ocular implant containing bevacizumab-loaded chitosan nanoparticles intended for choroidal neovascularization treatment","volume":"106","author":"Badiee","year":"2018","journal-title":"J. Biomed. Mater. Res. - Part A."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03959-4","article-title":"A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles","volume":"7","author":"Sousa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1685","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.biopha.2018.08.092","article-title":"Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy","volume":"107","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1690","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2018.02.003","article-title":"Human serum albumin nanoparticles for ocular delivery of bevacizumab","volume":"541","author":"Luis de Red\u00edn","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1695","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1002\/jbm.a.35446","article-title":"Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment","volume":"103","author":"Varshochian","year":"2015","journal-title":"J. Biomed. Mater. Res. - Part A."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1700","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107697","article-title":"In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization","volume":"185","author":"Luis de Red\u00edn","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1705","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/21691401.2016.1243545","article-title":"Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation","volume":"45","author":"Pandit","year":"2017","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1710","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1021\/nn305958y","article-title":"Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration","volume":"7","author":"Luo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1715","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2015.01.030","article-title":"Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy","volume":"202","author":"Martens","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1720","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1474-0","article-title":"An in vitro assessment of thermo-reversible gel formulation containing sunitinib nanoparticles for neovascular age-related macular degeneration","volume":"20","author":"Bhatt","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1725","first-page":"394","article-title":"Feasibility of drug delivery to the eye\u2019s posterior segment by topical instillation of PLGA nanoparticles, Asian","volume":"12","author":"Tahara","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/scipharm88030030","article-title":"Sunitinib-loaded MPEG-PCL micelles for the treatment of age-related macular degeneration","volume":"88","author":"Streets","year":"2020","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1735","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jddst.2018.07.003","article-title":"Rational design of liposomes for sustained release drug delivery of bevacizumab to treat ocular angiogenesis","volume":"47","author":"Karumanchi","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1740","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1745","series-title":"Comment on \u201cTopical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-Associated Liposomes\u201d: Topical Liposomal Bevacizumab Results in Negligible Retinal Concentrations, Small","first-page":"10","volume":"15","author":"Urtti","year":"2019"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1750","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1248\/yakushi.12-00234-3","article-title":"Non-invasive ophthalmic liposomes for nucleic acid delivery to posterior segment of eye","volume":"132","author":"Takashima","year":"2012","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1755","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jphotobiol.2018.04.033","article-title":"Development of facile drug delivery platform of ranibizumab fabricated PLGA-PEGylated magnetic nanoparticles for age-related macular degeneration therapy","volume":"183","author":"Yan","year":"2018","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1760","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1021\/acs.molpharmaceut.6b00335","article-title":"PLGA microparticles entrapping chitosan-based nanoparticles for the ocular delivery of ranibizumab","volume":"13","author":"Elsaid","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1765","first-page":"1","article-title":"Coaxial electrospray of ranibizumab-loaded microparticles for sustained release of anti-VEGF therapies","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.08.040_bb1770","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1021\/mp400487f","article-title":"Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab","volume":"10","author":"Yandrapu","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1775","first-page":"653","article-title":"Pharmacokinetics and distributions of bevacizumab by intravitreal injection of bevacizumab-PLGA microspheres in rabbits","volume":"8","author":"Ye","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1780","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2015.05.071","article-title":"An injectable thermosensitive polymeric hydrogel for sustained release of Avastin1 to treat posterior segment disease","volume":"490","author":"Xie","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1785","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijbiomac.2013.05.034","article-title":"Sustained release of avastin\u00ae from polysaccharides cross-linked hydrogels for ocular drug delivery","volume":"60","author":"Xu","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.08.040_bb1790","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1021\/acs.molpharmaceut.5b00828","article-title":"Composite nanoformulation therapeutics for long-term ocular delivery of macromolecules","volume":"13","author":"Agrahari","year":"2016","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:34:05Z","timestamp":1759163645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":358,"alternative-id":["S0168365922005466"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.040","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting formulation strategies for protein and peptide delivery in the treatment of PSED","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}